Curaleaf Holdings, Inc. (CURLF)

7.63
0.09 1.18
OTC
Prev Close 7.55
Open 7.51
Day Low/High 7.49 / 7.69
52 Wk Low/High 3.88 / 11.73
Volume 235.72K
Exchange OTC
Shares Outstanding 123.57B
Market Cap 932.96M
Div & Yield N.A. (N.A)

Latest News

Curaleaf Launches First Medical Cannabis Tablets In Florida

Curaleaf Launches First Medical Cannabis Tablets In Florida

New Product Available in All Curaleaf Medical Cannabis Dispensaries Statewide MIAMI, Sept.

Curaleaf Announces September Conference Attendance

Curaleaf Announces September Conference Attendance

WAKEFIELD, Mass., Sept.

Curaleaf Opens Port Charlotte's Largest Medical Cannabis Center

Curaleaf Opens Port Charlotte's Largest Medical Cannabis Center

Company's 26 th Florida Location Invites Community to FREE Weekly Educational Seminars PORT CHARLOTTE, Fla.

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors To Contact The Firm

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors To Contact The Firm

SAN DIEGO, Aug. 30, 2019 /PRNewswire/ -- Johnson Fistel, LLP announces that class action lawsuits have been commenced on behalf of shareholders of the publicly-traded companies listed below.

Curaleaf Second-Quarter Revenue Soars, Loss Widens

Curaleaf Second-Quarter Revenue Soars, Loss Widens

The cannabis operator reports second-quarter revenue of $48.5M, up from $14.6M a year ago.

Curaleaf Reports Second Quarter 2019 Financial And Operational Results

Curaleaf Reports Second Quarter 2019 Financial And Operational Results

Reported Record Pro Forma Revenue (1)(2) of $110.9 million and Managed Revenue (1) of $55.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Curaleaf Holdings, Inc. Of Class Action Lawsuit And Upcoming Deadline - CURLF

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Curaleaf Holdings, Inc. Of Class Action Lawsuit And Upcoming Deadline - CURLF

NEW YORK, Aug. 24, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Curaleaf Holdings, Inc.

Curaleaf Receives DTC Eligibility

Curaleaf Receives DTC Eligibility

WAKEFIELD, Mass., Aug.

Curaleaf Launches Veterans Cannabis Project Initiative In Oregon

Curaleaf Launches Veterans Cannabis Project Initiative In Oregon

Customers can now purchase custom Veterans Cannabis Project pre-rolls to support veterans' access to cannabis PORTLAND, Ore.

Curaleaf Completes Acquisition Of Glendale Greenhouse

Curaleaf Completes Acquisition Of Glendale Greenhouse

Curaleaf Continues To Make Meaningful Progress On Its Acquisition Strategy WAKEFIELD, Mass.

Glancy Prongay & Murray Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Curaleaf Holdings, Inc.

Glancy Prongay & Murray Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Curaleaf Holdings, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 4, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Curaleaf Holdings, Inc.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Curaleaf Holdings, Inc.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Curaleaf Holdings, Inc.

Law Offices of Howard G. Smith reminds investors of the upcoming October 4, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Curaleaf Holdings, Inc.

CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That

CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That

Agency has the authority to carve out an exception to existing laws.

ROSEN, A LEADING LAW FIRM, Reminds Curaleaf Holdings, Inc. Investors Of Important October 4th Deadline In Securities Class Action - CURLF

ROSEN, A LEADING LAW FIRM, Reminds Curaleaf Holdings, Inc. Investors Of Important October 4th Deadline In Securities Class Action - CURLF

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Curaleaf Holdings, Inc.

CURALEAF INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Curaleaf Holdings, Inc. To Contact The Firm

CURALEAF INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Curaleaf Holdings, Inc. To Contact The Firm

NEW YORK,, Aug. 8, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Curaleaf Holdings, Inc.

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Curaleaf Holdings, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Curaleaf Holdings, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Curaleaf Holdings, Inc.

TOP RANKED ROSEN LAW FIRM: Files First Securities Class Action Lawsuit Against Curaleaf Holdings, Inc. - CURLF

TOP RANKED ROSEN LAW FIRM: Files First Securities Class Action Lawsuit Against Curaleaf Holdings, Inc. - CURLF

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Curaleaf Holdings, Inc.

CURLF CLASS ACTION ALERT: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Curaleaf Holdings Inc.

CURLF CLASS ACTION ALERT: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Curaleaf Holdings Inc.

NEW YORK, Aug. 6, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of shareholders that purchased or acquired shares of Curaleaf...

INVESTOR ALERT - Curaleaf Holdings, Inc. (CURLF) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders Of Class Action And Lead Deadline: October 4, 2019

INVESTOR ALERT - Curaleaf Holdings, Inc. (CURLF) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders Of Class Action And Lead Deadline: October 4, 2019

NEW YORK, Aug. 6, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Curaleaf Holdings, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Curaleaf Holdings, Inc. - CURLF

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Curaleaf Holdings, Inc. - CURLF

NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Curaleaf Holdings, Inc.

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Curaleaf Holdings, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Curaleaf Holdings, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Curaleaf Holdings, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Curaleaf Holdings, Inc. - CURLF

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Curaleaf Holdings, Inc. - CURLF

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Curaleaf Holdings, Inc.

Curaleaf Tells FDA It Has Addressed Issues in Warning Letter

Curaleaf Tells FDA It Has Addressed Issues in Warning Letter

The cannabis company says it has removed from its website statements to which the FDA objected.